Literature DB >> 17879967

Mortality in achondroplasia study: a 42-year follow-up.

Julia Wynn1, Terri M King, Michael J Gambello, D Kim Waller, Jacqueline T Hecht.   

Abstract

Achondroplasia (ACH) is the most common dwarfing condition having a prevalence of 1/25,000 live births. An increase in overall mortality, age specific mortality up to age 34 years and heart disease-related mortality was first reported in a 1987 study of a large population of ACH individuals. Since this study, concern about premature death, particularly in young adults, has persisted in the ACH population. The present study was undertaken to follow-up the patterns of mortality in a more contemporaneous ACH population. The vital status of 718 ACH individuals from the original study and 75 new ACH individuals was determined through the search of two computerized mortality database. The results showed that the overall mortality and age-specific mortality at all ages remained significantly increased. Rates of death were similar across all 42 years of follow-up suggesting that higher death rates were still occurring in the contemporary ACH population. Accidental, neurological, and heart disease-related deaths were increased in adults. Heart disease-related mortality, between ages 25 and 35, was more than 10 times higher than the general population. Overall survival and the average life expectancy for this ACH population were decreased by 10 years. These results demonstrate that despite advances in the knowledge of the natural history of ACH and health care needs of this population, mortality remains significantly increased. The high rate of heart disease related deaths illustrates the need to identify risk factors in the ACH population and develop treatment interventions accordingly. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17879967     DOI: 10.1002/ajmg.a.31919

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  37 in total

1.  Coronary artery surgery in a man with achondroplasia: a case report.

Authors:  Georgios I Tagarakis; Dimos Karangelis; Andony J Baddour; Nicholas Desimonas; Angeliki Tsantsaridou; Marios E Daskalopoulos; Dimitrios Papadopoulos; Nikolaos B Tsilimingas
Journal:  J Med Case Rep       Date:  2010-10-29

2.  Pseudoachondroplasia and the seven Ovitz siblings who survived Auschwitz.

Authors:  Oliver J Muensterer; Walter E Berdon; Ralph S Lachman; Stephen L Done
Journal:  Pediatr Radiol       Date:  2012-03-18

3.  Disease models: Statins give bone growth a boost.

Authors:  Bjorn R Olsen
Journal:  Nature       Date:  2014-09-17       Impact factor: 49.962

4.  Surgical treatment for cervicomedullary compression among infants with achondroplasia.

Authors:  Nir Shimony; Liat Ben-Sira; Yakov Sivan; Shlomi Constantini; Jonathan Roth
Journal:  Childs Nerv Syst       Date:  2015-02-17       Impact factor: 1.475

Review 5.  Advanced paternal age and reproductive outcome.

Authors:  Zofnat Wiener-Megnazi; Ron Auslender; Martha Dirnfeld
Journal:  Asian J Androl       Date:  2011-12-12       Impact factor: 3.285

Review 6.  Male biological clock: a critical analysis of advanced paternal age.

Authors:  Ranjith Ramasamy; Koji Chiba; Peter Butler; Dolores J Lamb
Journal:  Fertil Steril       Date:  2015-04-14       Impact factor: 7.329

Review 7.  Achondroplasia: a comprehensive clinical review.

Authors:  Richard M Pauli
Journal:  Orphanet J Rare Dis       Date:  2019-01-03       Impact factor: 4.123

8.  Achondroplasia among ancient populations of mesoamerica and South America: Iconographic and Archaeological Evidence.

Authors:  Carlos A Rodríguez; Carolina Isaza; Harry Pachajoa
Journal:  Colomb Med (Cali)       Date:  2012-09-30

Review 9.  Neurological Manifestations of Achondroplasia.

Authors:  John B Bodensteiner
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-28       Impact factor: 5.081

10.  Advanced paternal age does not affect embryo aneuploidy following blastocyst biopsy in egg donor cycles.

Authors:  Robert J Carrasquillo; Taylor P Kohn; Cengiz Cinnioglu; Carmen Rubio; Carlos Simon; Ranjith Ramasamy; Nasser Al-Asmar
Journal:  J Assist Reprod Genet       Date:  2019-08-05       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.